Homology Medicines Inc (DELISTED) (FIXX:DL)
0.9347
-15.76
(-94.40%)
USD |
NASDAQ |
Mar 25, 16:00
0.92
-0.01
(-1.57%)
After-Hours: 20:00
Homology Medicines Research and Development Expense (Quarterly): 1.513M for Dec. 31, 2023
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.513M |
| September 30, 2023 | 17.52M |
| June 30, 2023 | 22.98M |
| March 31, 2023 | 19.99M |
| December 31, 2022 | 27.15M |
| September 30, 2022 | 25.85M |
| June 30, 2022 | 21.08M |
| March 31, 2022 | 24.27M |
| December 31, 2021 | 23.65M |
| September 30, 2021 | 23.99M |
| June 30, 2021 | 23.70M |
| March 31, 2021 | 21.76M |
| December 31, 2020 | 23.20M |
| September 30, 2020 | 20.42M |
| Date | Value |
|---|---|
| June 30, 2020 | 27.47M |
| March 31, 2020 | 29.31M |
| December 31, 2019 | 20.34M |
| September 30, 2019 | 25.69M |
| June 30, 2019 | 22.83M |
| March 31, 2019 | 20.54M |
| December 31, 2018 | 16.28M |
| September 30, 2018 | 13.39M |
| June 30, 2018 | 10.29M |
| March 31, 2018 | 7.997M |
| December 31, 2017 | 9.576M |
| September 30, 2017 | 4.947M |
| June 30, 2017 | 4.056M |
| March 31, 2017 | 2.799M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
1.513M
Minimum
Dec 2023
29.31M
Maximum
Mar 2020
22.25M
Average
23.20M
Median
Dec 2020
Research and Development Expense (Quarterly) Benchmarks
| Societal CDMO Inc (DELISTED) | -- |
| AgeX Therapeutics Inc (DELISTED) | 0.218M |
| NovaBay Pharmaceuticals Inc | 0.019M |
| Palatin Technologies Inc | 7.160M |
| iBio Inc | 1.535M |